Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis
剖析胰腺肿瘤发生过程中的 Hedgehog、TGF beta 和 BMP 信号传导
基本信息
- 批准号:8034649
- 负责人:
- 金额:$ 34.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-08 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAmericanBMPR2 geneBiochemicalBiologicalBiological ModelsCancer EtiologyCancer cell lineCell Culture TechniquesCell LineCellsCessation of lifeCollectionConflict (Psychology)DataDefectDevelopmentDiagnosisDiseaseDisease ProgressionEpithelialEpithelial CellsEpitheliumErinaceidaeEventFamilyFrequenciesGene Expression ProfilingGenesGeneticGenetic TranscriptionGli2 proteinIn VitroKRAS2 geneLeadLesionLigandsMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMolecularMutationOncogenesPancreasPancreatic Ductal AdenocarcinomaPathogenesisPathway interactionsPhenotypePhosphotransferasesPrimary Cell CulturesPublic HealthPublishingRelative (related person)Repressor MoleculesRoleSamplingSignal PathwaySignal TransductionSpecimenTransforming Growth Factor betaTumor Cell LineUnited StatesWorkautocrinebone morphogenetic protein receptorsbone morphogenic proteincancer cellcancer initiationcarcinogenesiscell behaviorin vivomortalitymouse modelnovelnovel therapeuticspancreatic cancer cellspancreatic neoplasmpancreatic tumorigenesisparacrinepostnatalreceptorresearch studysmall hairpin RNAsmoothened signaling pathwaystatisticstranscription factortumortumor progression
项目摘要
DESCRIPTION (provided by applicant): Pancreatic cancer is a leading cause of cancer-related mortality in the United States, with an estimated 35,000 people dying from this disease in 2009. Activating mutations in the KRAS2 oncogene occur in >90% of pancreatic ductal adenocarcinomas (PDAC), the most common type of pancreatic cancer, and are believed to be initiating lesions in PDAC. Elevated levels of hedgehog pathway components are found in a majority of PDAC specimens and cell lines. Loss of the Smad4 transcriptional regulator occurs in approximately half of PDAC cases, and inactivation of the TGF?RII, BMPRII, and ALK4 receptor kinases that act upstream of Smad4 occurs in a smaller subset of PDAC cases. Yet, the precise roles of the hedgehog pathway and the signaling pathways activated by TGF-? family ligands in PDAC remain unclear. This application therefore proposes to use a novel mouse modeling system and complementary cell culture and in vitro studies to systematically investigate the roles of these pathways in pancreatic carcinogenesis.
Prior studies have provided conflicting data on whether hedgehog ligands act in both autocrine and paracrine fashion, or only a paracrine manner, during pancreatic tumor development. Therefore, studies in Aim 1 will use novel mouse models to directly compare the ability of sonic hedgehog (Shh) and its downstream transcription factors Gli1 and Gli2 to cooperate with activated Kras during pancreatic tumorigenesis in vivo. Analyses of tumor samples and cell lines generated from the tumors induced in this Aim will be performed to determine whether Shh stimulates signaling in both the cancer cells and the reactive stroma, or only within the reactive stroma. Finally, using a novel dominant-repressor Gli3 allele, the requirement for Gli transcription activity in Kras-induced pancreatic tumorigenesis will be determined.
The studies in Aim 2 will identify the relative contributions of defects in TGF-? and BMP signaling to pancreatic tumorigenesis. ShRNAs targeting Smad4, TGF?RII, or BMPRII will be delivered specifically to the pancreatic epithelium in vivo, and their ability to cooperate with activated Kras determined. Complementary experiments in cancer cell lines derived from the induced tumors will be performed to determine whether defects in TGF-( or BMP signaling alter the phenotypes of pancreatic cancer cells, and how TGF-( family ligands influence pancreatic cancer cell behavior.
The studies in Aim 3 will determine whether there is cross-talk between the hedgehog and TGF-( signaling cascades in pancreatic cancer cells, and how this cross-talk influences the phenotypes of these cells. Finally, gene expression profiling will be used to identify important genes downstream of the hedgehog and TGF-( signaling cascades. The biological importance of these genes during pancreatic tumorigenesis will be validated using studies of the cancer cell lines generated in Aims 1 and 2, and the ability of these genes to cooperate with activated Kras during pancreatic tumorigenesis in vivo.
PUBLIC HEALTH RELEVANCE: Pancreatic cancer claims the lives of 35,000 Americans annually; therefore understanding the mechanisms that contribute to the initiation and progression of this disease is of great significance. Through the use of novel mouse models for pancreatic cancer, this application seeks to understand how alterations in the hedgehog, transforming growth factor beta, and bone morphogenic protein signaling pathways contribute to pancreatic cancer initiation and progression. These studies will significantly enhance the understanding of pancreatic cancer, and may lead to the development of novel therapeutic strategies, thereby reducing the impact of this disease on public health.
描述(由申请人提供):胰腺癌是美国癌症相关死亡的主要原因,2009年估计有35,000人死于该疾病。KRAS2癌基因的激活突变发生在90%的胰导管腺癌(PDAC)中,这是最常见的胰腺癌类型,并且被认为是PDAC的初始病变。在大多数PDAC标本和细胞系中发现了高水平的刺猬通路成分。Smad4转录调节因子的缺失发生在大约一半的PDAC病例中,TGF?RII, BMPRII和ALK4受体激酶作用于Smad4的上游,出现在PDAC病例的较小子集中。然而,刺猬通路和TGF-激活的信号通路的确切作用?PDAC的家族配体尚不清楚。因此,本应用程序建议使用一种新的小鼠建模系统和互补细胞培养和体外研究来系统地研究这些途径在胰腺癌发生中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN C LEWIS其他文献
BRIAN C LEWIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN C LEWIS', 18)}}的其他基金
Targeting MTOR signaling in pancreatic cancer
靶向胰腺癌中的 MTOR 信号传导
- 批准号:
10367271 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Targeting MTOR signaling in pancreatic cancer
靶向胰腺癌中的 MTOR 信号传导
- 批准号:
10617656 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Impact of circadian disruption on pancreatic cancer development and progression
昼夜节律紊乱对胰腺癌发生和进展的影响
- 批准号:
10531625 - 财政年份:2021
- 资助金额:
$ 34.39万 - 项目类别:
Impact of circadian disruption on pancreatic cancer development and progression
昼夜节律紊乱对胰腺癌发生和进展的影响
- 批准号:
10373645 - 财政年份:2021
- 资助金额:
$ 34.39万 - 项目类别:
IMSD at the University of Massachusetts Medical School
马萨诸塞大学医学院 IMSD
- 批准号:
10553216 - 财政年份:2020
- 资助金额:
$ 34.39万 - 项目类别:
IMSD at the University of Massachusetts Medical School
马萨诸塞大学医学院 IMSD
- 批准号:
10093106 - 财政年份:2020
- 资助金额:
$ 34.39万 - 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
- 批准号:
10080738 - 财政年份:2018
- 资助金额:
$ 34.39万 - 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
- 批准号:
10321902 - 财政年份:2018
- 资助金额:
$ 34.39万 - 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
- 批准号:
9416571 - 财政年份:2018
- 资助金额:
$ 34.39万 - 项目类别:
Pathway to graduate study post-baccalaureate training program
研究生学习途径 学士学位后培训计划
- 批准号:
10557496 - 财政年份:2018
- 资助金额:
$ 34.39万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 34.39万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 34.39万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 34.39万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 34.39万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 34.39万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 34.39万 - 项目类别:














{{item.name}}会员




